Deutsche Bank’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$645K Buy
65,123
+25,330
+64% +$212K ﹤0.01% 2633
2026
Q1
$244K Buy
39,793
+4,104
+11% +$34.1K ﹤0.01% 2923
2025
Q4
$297K Buy
35,689
+1,207
+4% +$13K ﹤0.01% 2831
2025
Q3
$503K Buy
34,482
+3,535
+11% +$42.3K ﹤0.01% 2538
2025
Q2
$348K Buy
30,947
+28,957
+1,455% +$224K ﹤0.01% 2644
2025
Q1
$11.3K Sell
1,990
-2,051
-51% -$20.9K ﹤0.01% 3495
2024
Q4
$39.7K Hold
4,041
﹤0.01% 3452
2024
Q3
$32.9K Buy
4,041
+2,217
+122% +$22.2K ﹤0.01% 3420
2024
Q2
$24.1K Sell
1,824
-70
-4% -$2.09K ﹤0.01% 3414
2024
Q1
$87.9K Buy
1,894
+216
+13% +$11.2K ﹤0.01% 3220
2023
Q4
$113K Sell
1,678
-11
-0.7% -$674 ﹤0.01% 3167
2023
Q3
$122K Buy
1,689
+1
+0.1% +$80 ﹤0.01% 3060
2023
Q2
$126K Buy
1,688
+1,620
+2,382% +$95.9K ﹤0.01% 3163
2023
Q1
$3.59K Sell
68
-2,968
-98% -$188K ﹤0.01% 3843
2022
Q4
$205K Buy
+3,036
New +$279K ﹤0.01% 2967
2022
Q3
Sell
-663
Closed -$63K 3993
2022
Q2
$63K Buy
+663
New +$80.9K ﹤0.01% 3692

Other funds holding DNA

Deutsche Bank's DNA Position: Q2 2026 in Review

Deutsche Bank increased its Ginkgo Bioworks (DNA) stake by 64% in Q2 2026, buying an estimated $212K and bringing the position to 65,123 shares worth $645K. The position accounts for ﹤0.01% of the portfolio, ranked #2633.

Deutsche Bank first reported a position in DNA in Q2 2022 and has held it in 16 quarters since. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Deutsche Bank held 65,123 shares of Ginkgo Bioworks worth $645K as of Q2 2026.
  • Deutsche Bank bought 25,330 Ginkgo Bioworks shares in Q2 2026, an estimated $212K.
  • Ginkgo Bioworks made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2633 holding.
  • Deutsche Bank first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 16 quarters since.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.